https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33907 Wed 23 Jan 2019 10:40:24 AEDT ]]> Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29481 n = 144, 71%), followed by mouth spray (n = 84, 42%) and vaporiser (n = 83, 41%). Explanations for preferences (n = 134) most commonly cited convenience (n = 66; 49%). A total of 82% (n = 168) of respondents indicated that they had no trial-related concerns, but a small number volunteered concerns about adverse effects (n= 14) or wanted more information/advice (n = 8). Six respondents volunteered a belief that cannabis might cure cancer, while two wanted assurance of efficacy before participating in a trial. Conclusion: Justification of modes other than tablets/capsules and variable understanding about cannabis and trials will need addressing in trial-related information to optimise recruitment and ensure that consent is properly informed.]]> Wed 17 Nov 2021 16:32:30 AEDT ]]> Follow-up cancer care: perspectives of Aboriginal and Torres Strait Islander cancer survivors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31511 Wed 15 Dec 2021 16:09:40 AEDT ]]> Lessons learned from a pilot study of an Indigenous patient navigator intervention in Queensland, Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35280 Thu 27 Jan 2022 15:59:02 AEDT ]]> Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51846 Thu 21 Sep 2023 09:27:34 AEST ]]> Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32156 Mon 23 Sep 2019 10:49:32 AEST ]]> The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32153 Mon 07 May 2018 14:14:20 AEST ]]> Worldwide comparison of ovarian cancer survival: histological group and stage at diagnosis (CONCORD-2) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32152 Fri 05 Jul 2024 13:38:41 AEST ]]> Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45694 Fri 04 Nov 2022 09:13:22 AEDT ]]>